Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries

Table 3 Antenatal corticosteroid use by level of care

	Latin America	South Asia	sub-Saharan Africa
	Argentina	Chimaltenango, Guatemala	India, Belgaum	India, Nagpur	Thatta, Pakistan	Kafue, Zambia	W. Provence, Kenya
Women with small (<5th %ile) babies and ACS use reported, N	142	181	808	336	816	243	199
Received any antepartum steroids by location of delivery¹
Hospitals (overall), n (%)	61/137 (44.5)	21/94 (22.3)	80/645 (12.4)	14/252 (5.6)	21/342 (6.1)	7/63 (11.1)	2/53 (3.8)
Facilities with maternal and neonatal care capabilities²	57/131 (43.5)	16/62 (25.8)	40/198 (20.2)	12/163 (7.4)	12/214 (5.6)	0/0 (0.0)	1/25 (4.0)
Clinic, n (%)	0/0 (0.0)	0/3 (0.0)	8/95 (8.4)	1/43 (2.3)	7/162 (4.3)	1/101 (1.0)	1/62 (1.6)
Home, n (%)	0/1 (0.0)	0/78 (0.0)	1/67 (1.5)	0/23 (0.0)	1/312 (0.3)	0/72 (0.0)	1/84 (1.2)

¹Denominator includes all births at facilities typically utilized by MNH participants and home births. ²Care capabilities include cesarean section, neonatal bag and mask, and neonatal oxygen or mechanical ventilation. It is further limited to those with data available on steroid administration

ISSN: 1742-4755